Geneos Wealth Management’s Scansource SCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-400
Closed -$13K 2766
2022
Q1
$13K Hold
400
﹤0.01% 1985
2021
Q4
$14K Hold
400
﹤0.01% 2055
2021
Q3
$14K Hold
400
﹤0.01% 2092
2021
Q2
$11K Hold
400
﹤0.01% 2175
2021
Q1
$12K Hold
400
﹤0.01% 2306
2020
Q4
$12K Hold
400
﹤0.01% 2153
2020
Q3
$7K Hold
400
﹤0.01% 2084
2020
Q2
$8K Hold
400
﹤0.01% 1996
2020
Q1
$8K Hold
400
﹤0.01% 1905
2019
Q4
$14K Hold
400
﹤0.01% 1849
2019
Q3
$12K Hold
400
﹤0.01% 1820
2019
Q2
$13K Hold
400
﹤0.01% 1823
2019
Q1
$14K Hold
400
﹤0.01% 1722
2018
Q4
$13K Hold
400
﹤0.01% 1702
2018
Q3
$15K Hold
400
﹤0.01% 1711
2018
Q2
$16K Sell
400
-320
-44% -$12.1K ﹤0.01% 1548
2018
Q1
$25K Hold
720
﹤0.01% 1307
2017
Q4
$25K Buy
720
+370
+106% +$14.4K ﹤0.01% 1300
2017
Q3
$15K Buy
350
+150
+75% +$5.9K ﹤0.01% 1438
2017
Q2
$8K Hold
200
﹤0.01% 1608
2017
Q1
$7K Sell
200
-28
-12% -$1.14K ﹤0.01% 1608
2016
Q4
$9K Hold
228
﹤0.01% 1478
2016
Q3
$8K Buy
228
+28
+14% +$1.09K ﹤0.01% 1456
2016
Q2
$7K Hold
200
﹤0.01% 1439
2016
Q1
$8K Buy
+200
New +$6.97K ﹤0.01% 1395

Other funds holding SCSC

Geneos Wealth Management's SCSC Position: Q2 2022 in Review

Geneos Wealth Management sold out of Scansource (SCSC) in Q2 2022, closing a stake of 400 shares — an estimated $13K sold.

Geneos Wealth Management first reported a position in SCSC in Q1 2016 and held it in 25 quarters. The position peaked at $25K in Q1 2018. 164 funds tracked by Wall St. Rank hold SCSC as of Q2 2022.

  • Geneos Wealth Management reported no remaining Scansource position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 400 Scansource shares in Q2 2022, an estimated $13K.
  • Geneos Wealth Management first reported a position in Scansource in Q1 2016 and held it in 25 quarters.
  • Geneos Wealth Management's Scansource position peaked at $25K in Q1 2018.
  • 164 funds tracked by Wall St. Rank held Scansource as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.